Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jalanko

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
FEBS Letters|July 1, 1985
Expression of Semliki Forest virus capsid protein from SV40 recombinant virusA Jalanko
Virology|March 1, 1985
The repeated regions of Semliki Forest virus defective-inferfering RNA interferes with the encapsidation process of the standard virusA Jalanko, H Söderlund
Gene|September 1, 1981
Restriction maps of plasmids pUB110 and pBD9A Jalanko, I Palva, Söderlund
Human Molecular Genetics|September 2, 1999
Molecular genetics of the Finnish disease heritageL Peltonen, A Jalanko, T Varilo
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1996
[Diseases and gene defects]A Jalanko, M Ranki, L Palotie
Human Molecular Genetics|March 1, 1995
Deletion of the C-terminal end of aspartylglucosaminidase resulting in a lysosomal accumulation disease: evidence for a unique genomic rearrangementA Jalanko, T Manninen, L Peltonen
Archives of Virology|January 1, 1988
Comparison of mammalian cell expression vectors with and without an EBV-repliconA Jalanko, A Kallio, I Ulmanen
Gene|May 30, 1989
Efficient synthesis of influenza virus hemagglutinin in mammalian cells with an extrachromosomal Epstein-Barr virus vectorA Jalanko, A Kallio, M Salminen, et al.
Human Gene Therapy|June 1, 1995
Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transferN Enomaa, O Danos, L Peltonen, et al.
Journal of Biotechnology|July 1, 1990
Production of human tissue-type plasminogen activator in different mammalian cell lines using an Epstein-Barr virus vectorA Jalanko, J Pirhonen, G Pohl, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
FEBS Letters|July 1, 1985
Expression of Semliki Forest virus capsid protein from SV40 recombinant virusA Jalanko
Virology|March 1, 1985
The repeated regions of Semliki Forest virus defective-inferfering RNA interferes with the encapsidation process of the standard virusA Jalanko, H Söderlund
Gene|September 1, 1981
Restriction maps of plasmids pUB110 and pBD9A Jalanko, I Palva, Söderlund
Human Molecular Genetics|September 2, 1999
Molecular genetics of the Finnish disease heritageL Peltonen, A Jalanko, T Varilo
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1996
[Diseases and gene defects]A Jalanko, M Ranki, L Palotie
Human Molecular Genetics|March 1, 1995
Deletion of the C-terminal end of aspartylglucosaminidase resulting in a lysosomal accumulation disease: evidence for a unique genomic rearrangementA Jalanko, T Manninen, L Peltonen
Archives of Virology|January 1, 1988
Comparison of mammalian cell expression vectors with and without an EBV-repliconA Jalanko, A Kallio, I Ulmanen
Gene|May 30, 1989
Efficient synthesis of influenza virus hemagglutinin in mammalian cells with an extrachromosomal Epstein-Barr virus vectorA Jalanko, A Kallio, M Salminen, et al.
Human Gene Therapy|June 1, 1995
Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transferN Enomaa, O Danos, L Peltonen, et al.
Journal of Biotechnology|July 1, 1990
Production of human tissue-type plasminogen activator in different mammalian cell lines using an Epstein-Barr virus vectorA Jalanko, J Pirhonen, G Pohl, et al.
Pageof 6